Octapharma AG: Final data from the NuProtect study published on the immunogenicity of Nuwiq® in previously untreated patients with severe haemophilia A ...Middle East

LACHEN, Switzerland, Feb. 22, 2021 /PRNewswire/ -- Octapharma announced today that the final results from the NuProtect study on the immunogenicity of Nuwiq® in previously untreated patients (PUPs) with severe haemophilia A have been published in the leading medical journal Thrombosis and...

Hence then, the article about octapharma ag final data from the nuprotect study published on the immunogenicity of nuwiq in previously untreated patients with severe haemophilia a was published today ( Monday 22/02/2021 - 07:30 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Octapharma AG: Final data from the NuProtect study published on the immunogenicity of Nuwiq® in previously untreated patients with severe haemophilia A )

Also on site :

• Mayor seguridad en el almacenamiento de energía: Sungrow y TÜV Rheinland presentan su informe técnico
• StanChart: Europe’s Gas Prices Could Spike Above $90/MWh By The Summer
• Namibia: Parliament Fears 'Power Vacuum' in Petroleum Bill